by Mosquito borne diseases continue to impose an enormous public health challenge globally impacting millions every year. Diagnostic devices like thermometers, pulse oximeters and mobile apps play a pivotal role in detecting these viral diseases early and enabling accurate preventive treatment. Regular monitoring helps assess patients’ health status and track disease progression. New technologies are increasingly being adopted by healthcare providers and consumers to curb the spread of infections through prevention and community awareness programs.
The global Mosquito Borne Disease Diagnostic and Prevention Market is estimated to be valued at US$ 3.59 Billion in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
With growing cases of vector borne infections, governments and aid agencies are ramping up detection and prevention efforts. This is driving innovations in monitoring solutions. Portable and wearable diagnostic kits are gaining popularity due to their ease of use. Players are focusing on launching affordable rapid test kits that can provide lab-quality results within minutes. Telehealth and mobile diagnostics are emerging as cost-effective alternatives to hospital visits. Technology giants are partnering with health authorities to develop AI-powered apps and devices integrated with GPS to identify mosquito breeding hotspots and map disease spread in real-time. Community-driven awareness campaigns promoted through social media platforms are encouraging at-risk populations to take preventive measures like using insect repellents and sprays.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the mosquito-borne disease market size is moderate as it requires significant R&D investments and compliance with regulations to develop drugs and diagnostics.
Bargaining power of buyers: The bargaining power of buyers in the mosquito-borne disease market is high due to the presence of many established players offering generic drugs and diagnostic devices.
Bargaining power of suppliers: The bargaining power of suppliers in the mosquito-borne disease market is low as there are many suppliers for raw materials.
Threat of new substitutes: The threat of new substitutes in the mosquito-borne disease market is low as there are limited treatment substitutes available for diseases like dengue, malaria.
Competitive rivalry: The competitive rivalry in the mosquito-borne disease market is high due to the presence of many global and regional players offering comparable drug therapies and diagnostic tests.
Key Takeaways
The global Mosquito Borne Disease Market is expected to witness high growth over the forecast period of 2024 to 2031. The global Mosquito Borne Disease Diagnostic and Prevention Market is estimated to be valued at US$ 3.59 Billion in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.
Regional analysis: The Asia Pacific region dominates the mosquito-borne disease market currently due to the high prevalence of mosquito-borne diseases like dengue and malaria. Countries like India, Indonesia, and Thailand report the highest number of cases annually.
Key players: Key players operating in the Mosquito Borne Disease market are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed . Masimo and Medtronic captured over 15% of the market share due to their diversified product portfolio.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
